Status:
COMPLETED
Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Insulin Resistance
Metabolic Syndrome X
Eligibility:
All Genders
55-69 years
Brief Summary
The aim of the study is to describe an immune activation profile of people at risk of insulin resistance based on a wide range of markers which will allow easy identification of patients at risk.
Eligibility Criteria
Inclusion
- The patient has been informed of the study, its objectives, constraints and the patient rights
- The patient must have given their free and informed consent and signed the consent form
- The patient is aged 55-69
Exclusion
- The subject is participating in an interventional category 1 study
- The patient has participated in another category 1 interventional study in the last 3 months
- The patient is in a period of exclusion determined by a previous study
- The patient is under safeguard of justice or state guardianship
- The subject refuses to sign the consent
- The subject does not understand the information
Key Trial Info
Start Date :
December 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2018
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT03309761
Start Date
December 11 2017
End Date
August 20 2018
Last Update
November 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nimes
Nîmes, France, 30029
2
Centre d'examen de santé de la Sécurité Sociale de Nîmes
Nîmes, France